Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

Autophagy

Autophagy is a catabolic process which degrades and recycles long-lived proteins and cytoplasmic organelles through lysosome. It plays an important role in growth regulation and maintenance of homeostasis.

Items 1-10 of 32

Page
per page
  1. Doxorubicin
    A3966 Doxorubicin
     3 Citation
    Summary: Topo II inhibitor,immunosuppresive antineoplastic antibiotic
      ≥27.2 mg/mL
  2. LY 294002
    A8250 LY 294002
     16 Citation
    Target: PI3K
    Summary: Potent PI3K inhibitor
  3. Omeprazole
    A2845 Omeprazole
    Summary: H+,K+-ATPase inhibitor
      insoluble in H2O; insoluble in EtOH; ≥17.27 mg/mL
  4. Dexamethasone (DHAP)
    A2324 Dexamethasone (DHAP)
    Target: interleukin receptor
    Summary: Glucocorticoidan; anti-inflammatory
      insoluble in H2O; ≥19.623 mg/mL
  5. 3-Methyladenine
    A8353 3-Methyladenine
     3 Citation
    Target: PI3K
    Summary: Class III PI3K inhibitor
      ≥5 mg/mL
  6. Nimodipine
    A8484 Nimodipine
    Summary: Calcium Channel inhibitor & Autophagy activator
      ≥41.8 mg/mL
  7. Nocodazole
    A8487 Nocodazole
     1 Citation
    Target: Microtubules/Tubulins
    Summary: Tubulin production inhibitor,anti-neoplastic agent
      insoluble in H2O; insoluble in EtOH; ≥15.066 mg/mL
  8. Wortmannin
    A8544 Wortmannin
     5 Citation
    Summary: PI3K inhibitor,selective and irreversible
      ≥21.42 mg/mL
  9. Bafilomycin A1
    A8627 Bafilomycin A1
     5 Citation
    Summary: V-ATPase inhibitor,selective and reversible
      Soluble in DMSO
  10. Chloroquine diphosphate
    A8628 Chloroquine diphosphate
     1 Citation
    Target: Autophagy
    Summary: Antimalarial drug,TLR7 TLR9 inhibitor
      insoluble in DMSO; insoluble in EtOH; ≥106.06 mg/mL

Items 1-10 of 32

Page
per page